Pharmaceutical Manufacturing Facility For Sale In Nagpur
Email
Phone
Google
LinkedIn
Facebook
Product / Service
Their product line includes bulk drugs such as Cefuroxime Axtel USP Taste Masked Granules for 125 mg and 250 mg oral suspension, available in 25/50kg drums, and Cefixime Trihydrate Tablets USP DC, along with Cefpodoxime Proxetil DT Tablets USP DC.
Clientele type
Their client base extends globally, currently exporting to countries such as the Philippines, Congo, Yemen, Dubai, Mauritania, Serbia, Iraq, and beyond.
They also offers Contract Manufacturing, P2P, and Third Party.
Premises
The total Built-up area is 36,000 sq. Ft.
Ground Floor 18,000 Sq. Ft + First Floor 18,000 Sq. Ft.
Asking Price Includes
The asking price includes the complete setup of the plant.
Reason
They are exiting due to personal reasons that would be disclosed to potential buyers.
Other Details
They operate an operational plant and are dedicated to manufacturing Cephalosporins formulations.
As a partnership firm, they are situated on an industrial NA plot within a privately owned land zone near Nagpur. Their WHO-GMP certification is valid until March 2024, and they have secured various approvals, including a Neutral Code Certificate for Export, a State GMP certificate, and product approvals. Furthermore, they have obtained all required government approvals related to industrial land and pollution department regulations.
The products have significant market potential in the near future, especially considering the following factors:
Cephalosporin Market Classification:
The Cephalosporin market falls under the anti-infective category, indicating its crucial role in combating infections.
Contribution to the Anti-infective Market:
According to the IQVIA-Market Annual Report 2022, Cephalosporins accounted for approximately 43% of the total anti-infective market and exhibited a growth rate of 6% in 2022.
Position in the Indian Pharma Market:
In January 2023, IQVIA reported that anti-infective drugs held the second position in terms of value, with a share of INR 1,877 crore out of the total Indian Pharma Market valued at INR 1,94,467 crore.
Key Highlights
1. Three trademarks are registered and 40 Approved Products for domestic & export.
2. Formulated own oral suspension Cefuroxime Axetil 250 mg USP which is manufactured by fewer manufacturers.
3. The value of land appreciated 200% in the last three years.
4. District Industries Cooperation of Maharashtra has sanctioned a subsidy of INR 6.87 Cr to be disbursed in the next 10 years. The first part of the subsidy is to be disbursed in a couple of months.
5. 5 acres of industrial NA freehold land out of which only 18,000 sq. ft is utilized. Rest is available for expansion.
6. Tablets and Dry Syrup sections are in place. The capsule section just got approval.
7. Supplying to major pharmacy chains in India.
8. Having three major companies' loan licenses.
9. Factory Located in central India.
10. Factory is just 1 hour from Nagpur International Airport.
11. Pollution-free environment which is most favorable for pharmaceutical industries.
12. Low labor cost.
13. Low electricity tariff charges and having a smooth supply of electricity.
Keywords
Business Tags
₹10 to ₹200 Cr
Complete Investment Banking Solution in 120 Days
Seamless Fundraising/M&A transactions
Start your growth journey with our 25+ Years of Experienced Professional Team.
Contact IBGrid TeamFrequently Asked Questions
How to contact a business owner directly to buy or invest in a business?
Connecting with a business owner directly is simple! Just follow these 3 easy steps: 1. Create your FREE Investor/Buyer profile on IndiaBizForSale 2. Explore the 'Business Opportunities' section to find 10,000+ business opportunities matching your investment preferences. 3. Click on the 'Contact Business' button and connect with business owner directly. Check here to know how it worksNote: Once you create your profile, you will get ONE introduction credit, allowing you to contact any ONE featured business.
How does IndiaBiz verify the business information?
The business opportunity is either posted by the business owner or advisor. After that, our team checks the information for completeness, language, and accuracy. Once the basic checks are met; only then the opportunity is published. We also get users' feedback for the opportunities they contact and based on their feedback, the opportunity maybe put on HOLD till further clarification. Many opportunities are not published when it does not pass through our internal procedure checks. We sincerely request you to carry out complete due diligence before taking the transaction ahead. In addition, the contact details of the business are verified via phone/email.
What to consider before buying or investing in a business?
Below are some of the factors that need to be considered before buying or investing in a business:- Growth prospects of the industry and business
- Sales, profitability, and cash flow of the business should be considered
- Consideration you have to pay; form of consideration (either cash or shares or some combination of both) to be paid?
- Source of financing the purchase
- Amount of additional investment that will be required to grow business
- Does the business have second-line of management?
- Are you going to run the business on day-to-day basis or appoint some professional for the same?
- What decisions are to be taken to improve the profitability of the business?
- Time period of payback or return is envisaged from the business?
- Any long-term strategic benefit or synergy with your existing business?
- Will the clients continue with the business after the acquisition?
